Acquiring Company
Concentra Biosciences
Acquired Company
CARGO Therapeutics
San MateoBiotechnologyDescription
Concentra Biosciences, LLC has reached an agreement to acquire CARGO Therapeutics, Inc. for $4.379 in cash per share, plus additional contingent rights. This deal includes rights to potential future proceeds from specific therapies developed by CARGO. The acquisition is part of Concentra's strategy to enhance its portfolio in cellular therapies. Shareholder approvals and further details will be finalized soon.
Quick answer
Concentra Biosciences is acquiring CARGO Therapeutics, announced July 25, 2025.
- How much did Concentra Biosciences pay for CARGO Therapeutics?
- The deal value was not disclosed.
- Where are Concentra Biosciences and CARGO Therapeutics based?
- CARGO Therapeutics is based in San Mateo, California, United States.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Edwards Lifesciences acquires Vectorious for $497M, $497M (September 4, 2025)
- Mukka Proteins acquires majority stake in FABBCO (September 3, 2025)
- Gryphon Digital Technologies merges with American Bitcoin (August 29, 2025)
- Kemin Industries acquires Hennessy Research Associates (August 27, 2025)
- Driving Force acquires VMA technology from Wenzel Spine (August 27, 2025)
- Northwest Biotherapeutics to acquire Advent BioServices (August 27, 2025)
Who to call at Concentra Biosciences, and when
When Concentra Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Concentra Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Concentra Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Concentra Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Concentra Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired CARGO Therapeutics?
CARGO Therapeutics was acquired by Concentra Biosciences. The deal was reported on July 25, 2025. Concentra Biosciences is privately held.
When did Concentra Biosciences acquire CARGO Therapeutics?
Concentra Biosciences's acquisition of CARGO Therapeutics was reported on July 25, 2025. Concentra Biosciences, LLC has reached an agreement to acquire CARGO Therapeutics, Inc. for $4.379 in cash per share, plus additional contingent rights. This deal includes rights to potential future proceeds from specific therapies developed by CARGO. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CARGO Therapeutics do?
Cargo Therapeutics is a biopharmaceutical company focused on developing CAR-T cell therapies for blood cancers. The company recently faced significant challenges with the discontinuation of its therapy firi-cabtagene autoleucel. It is privately held, operating in Biotechnology, and is based in San Mateo.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.